Showing 1,281 - 1,300 results of 2,092 for search '"chemotherapy"', query time: 0.05s Refine Results
  1. 1281

    The crosstalk between SND1 and PDCD4 is associated with chemoresistance of non-small cell lung carcinoma cells by Yun Zhao, Shanel Dhani, Vladimir Gogvadze, Boris Zhivotovsky

    Published 2025-01-01
    “…Thus, a novel correlation interlinking SND1 and PDCD4 in the regulation of NSCLC cells concerning chemotherapy was revealed, which contributes to understanding the mechanisms of chemoresistance in NSCLC.…”
    Get full text
    Article
  2. 1282

    Early Gastric Post-Transplant Lymphoproliferative Disorder and H pylori Detection after Kidney Transplantation: A Case Report and Review of the Literature by CL Nash, LM Price, DA Stewart, F Sepandj, S Yilmaz, A Barama

    Published 2000-01-01
    “…Treatment modalities consist of decreased immunosuppression, eradication of Epstein-Barr virus, surgical resection, systemic chemotherapy and monoclonal antibody therapy; however, mortality remains high, typically with a short survival time. …”
    Get full text
    Article
  3. 1283

    Pulmonary Kaposi Sarcoma: An Uncommon Cause of Respiratory Failure in the Era of Highly Active Antiretroviral Therapy—Case Report and Review of the Literature by Stanley M. Nwabudike, Stefan Hemmings, Yonette Paul, Yordanis Habtegebriel, Octavius Polk, Alem Mehari

    Published 2016-01-01
    “…First-line treatment of KS is with HAART and the incidence has declined with its use. Systemic chemotherapy may play a role depending on the extent of the disease. …”
    Get full text
    Article
  4. 1284

    Targeting Cancer Stem Cells and Their Niche: Current Therapeutic Implications and Challenges in Pancreatic Cancer by Jiangang Zhao, Jiahui Li, Hans A. Schlößer, Felix Popp, Marie Christine Popp, Hakan Alakus, Karl-Walter Jauch, Christiane J. Bruns, Yue Zhao

    Published 2017-01-01
    “…In this review, we summarize the characteristics of pancreatic CSCs and discuss the mechanisms involved in resistance to chemotherapy, the interactions with the niche, and the potential role in cancer immunoediting. …”
    Get full text
    Article
  5. 1285

    Doxorubicin-Conjugated Nanoparticles for Potential Use as Drug Delivery Systems by Alua Imantay, Nariman Mashurov, Balnur A. Zhaisanbayeva, Ellina A. Mun

    Published 2025-01-01
    “…Doxorubicin (DOX) is one of the most widely used chemotherapy drugs in the treatment of both solid and liquid tumors in patients of all age groups. …”
    Get full text
    Article
  6. 1286

    Topical Application of Fasudil Hydrochloride for Vasospasm during Soft Tissue Reconstruction Using a Free Flap by Kaoru Tada, Tadahiro Nakajima, Mika Nakada, Masashi Matsuta, Hiroyuki Tsuchiya

    Published 2019-01-01
    “…A 36-year-old man underwent preoperative chemotherapy and wide excision for a malignant soft tissue tumor around the knee joint. …”
    Get full text
    Article
  7. 1287

    Evaluation of Absolute Neutrophil Count in the Perioperative Setting of Sarcoma Resection by Gayathri Vijayakumar, Emma M. Steffer, Neil P. Buac, Matthew W. Colman, Steven Gitelis, Alan T. Blank

    Published 2024-01-01
    “…Preoperatively, many patients receive chemotherapy and may develop neutropenia. No study has evaluated the effect of a low preoperative absolute neutrophil count (ANC) on postoperative outcomes following LSS. …”
    Get full text
    Article
  8. 1288

    Peripheral T Cell Non-Hodgkin’s Lymphoma following Treatment of Hodgkin’s Lymphoma by Sun Hee Chang, Hye Ran Lee

    Published 2015-01-01
    “…Therefore, we may need to ensure pathological confirmation, especially in case of lymphoma that did not respond to chemotherapy.…”
    Get full text
    Article
  9. 1289

    A Patient with a Right Atrium Mass and Congenital Heart Disease: A Challenging Diagnosis of a Stubborn Disease by Wenyan Wang, Huaicong Long, Zhiying Zhao

    Published 2016-01-01
    “…The patient died without any chemotherapy 18 days after hospital discharge.…”
    Get full text
    Article
  10. 1290

    Characteristics and Prognostic Nomogram for Primary Lung Lepidic Adenocarcinoma by Hui Tang, Caixia Qiao, Yingyi Wang, Chunmei Bai

    Published 2022-01-01
    “…Multivariate analyses showed that age, sex, race, tumor location, primary tumor size, pleural invasion, histological grade, stage, primary tumor surgery, and chemotherapy were independently associated with overall survival (OS) and cancer-specific survival (CSS) in patients with LPA. …”
    Get full text
    Article
  11. 1291

    Prevalence of platinum-induced ototoxicity among patients suffering from hematological malignancies – a systematic review by Aleksandra Janowiak-Majeranowska, Gazala Abdulaziz-Opiela, Jakub Osowski, Bogusław Mikaszewski

    Published 2024-07-01
    “…Following Preferred Reporting Items for Systematic Reviews and meta- analyses guidelines, a systematic review was conducted to assess the incidence of ototoxicity among hematology patients undergoing platinum compound-based chemotherapy. Four databases – PubMed, Scopus, Embase, and Web of Science – were searched to identify relevant articles published in the period 2000–2023. …”
    Get full text
    Article
  12. 1292
  13. 1293

    Primary Hepatic Lymphoma: A Challenging Diagnosis by D. Myoteri, D. Dellaportas, E. Arkoumani, A. Marinis, A. Zizi-Sermpetzoglou

    Published 2014-01-01
    “…After CT-guided biopsy, primary diffuse large B-cells non-Hodgkin lymphoma was revealed. Appropriate chemotherapy improved patient’s condition markedly. Discussion. …”
    Get full text
    Article
  14. 1294
  15. 1295

    The Evaluation of Uterine Sarcomas: Tertiary Center Experience by Onur Yavuz, Kadir Alper Mankan, Asli Akdoner, Sultan Ot, Hasan Bahadir Saatli

    Published 2024-08-01
    “…No statistically significant effect of adjuvant systemic chemotherapy, adjuvant radiotherapy, and combined treatments on median overall survival and median disease-free survival was detected (p>0.05). …”
    Get full text
    Article
  16. 1296

    Merkel Cell Carcinoma of the Retroperitoneum with No Identifiable Primary Site by Daniele Rossini, Salvatore Caponnetto, Vittoria Lapadula, Lucilla De Filippis, Gabriella Del Bene, Alessandra Emiliani, Flavia Longo

    Published 2013-01-01
    “…While being an atypical presentation, the tumor mass showed an excellent response to the combination of chemotherapy followed by radiotherapy.…”
    Get full text
    Article
  17. 1297

    Pure Large Cell Neuroendocrine Carcinoma of Ovary: A Rare Clinical Entity and Review of Literature by P. N. Shakuntala, K. Uma Devi, K. Shobha, U. D. Bafna, M. Geetashree

    Published 2012-01-01
    “…Surgical debulking and five cycles of chemotherapy (Etoposide and Cisplatin) were administered to the woman. …”
    Get full text
    Article
  18. 1298

    Th22 Cells/IL-22 Serves as a Protumor Regulator to Drive Poor Prognosis through the JAK-STAT3/MAPK/AKT Signaling Pathway in Non-Small-Cell Lung Cancer by Yinan Yao, Guangdie Yang, Guohua Lu, Jiani Ye, Luyun Cui, Zhu Zeng, Junjun Chen, Jianying Zhou

    Published 2022-01-01
    “…Furthermore, IL-22 not only antagonized the apoptosis inducing and cell cycle arresting effect by chemotherapy and molecular targeted drugs on NSCLC cell lines but also promoted tumor cell proliferation and tumor tissue growth. …”
    Get full text
    Article
  19. 1299

    Advanced anaplastic thyroid carcinoma with positive expression of PD-L1 response to immune checkpoint inhibitors: A case report by Shanmin Fan, Yang Yuan, Yanfang Su, Die Sang

    Published 2025-01-01
    “…However, there have been no research of immune checkpoint inhibitors plus chemotherapy in ATC. Here, we present the case of a 37-year-old man with metastatic ATC with positive PD-L1 expression, who achieved long-term remission of 34 months after later-line treatment with zimberelimab (a PD-1 inhibitor) and nab-paclitaxel, followed by single-agent zimberelimab maintenance therapy. …”
    Get full text
    Article
  20. 1300

    Glioma Stem Cells: Signaling, Microenvironment, and Therapy by Brandon D. Liebelt, Takashi Shingu, Xin Zhou, Jiangong Ren, Seul A. Shin, Jian Hu

    Published 2016-01-01
    “…Glioblastoma remains the most common and devastating primary brain tumor despite maximal therapy with surgery, chemotherapy, and radiation. The glioma stem cell (GSC) subpopulation has been identified in glioblastoma and likely plays a key role in resistance of these tumors to conventional therapies as well as recurrent disease. …”
    Get full text
    Article